BRONXVILLE, NY—New York-Presbyterian/Lawrence Hospital in Bronxville, NY announces the opening of a NEW Interventional Cardiac Catheterization Lab Program in early 2015.
On Monday, February 9, 4:00pm - 8:30pm, you have an opportunity to network with the Cath Lab team at NYP/Lawrence, tour their brand new Cath Lab, and hear about available career opportunities for Registered Nurses, Physician Assistants, and Angioplasty Specialists.
Continue reading New Cath Lab Opening in Bronxville, New York
Platte Valley Medical Center is hosting three days of ACVP educational events in Brighton, Colorado, including an exciting two-day Cardio Conference February 12-13, and a CCI Exam Review session February 14.
We sat down with PVMC Cath Lab Director Mark Baker, RCIS, MICP, RCSA, CTAE to talk about what's in store.
What motivated you to host?
There's not a lot of education of this type out here in Colorado. They don't have a lot of education that's geared towards Allied Health. In the northeast region in Colorado, there are not a lot of large hospitals, so getting education in difficult. If there is anything, it's usually in Denver.
What about the upcoming meeting are you most excited about?
I invited physicians that I know from Alaska. Some of the methodologies for care [there] are a little bit different. Having our staff see these different points of view, that's what I'm most excited about. I think it's going to stir up a lot of conversation about how we're doing things now and how we should do them in the future.
Continue reading Interview with Mark Baker, Cath Lab Director at Platte Valley Medical Center
DID YOU HEAR? If you aren't already, you may be in for weekend shifts in the Cath Lab—continue reading to find out WHY.
A recent study published by the British Heart Foundation found that a new, more sensitive and gender-specific troponin test developed by ACVP partner Abbott could double rates of heart attack diagnosis in women.
As it stands, despite statistics showing that men and women die from heart disease at equal rates in the US, only ten percent of women reporting chest pains will be diagnosed with a heart attack as opposed to twenty percent of men.
This inaccurate spread results from a single diagnostic threshold for both men and women, despite the fact that troponin levels can be twice as high in men than in women.
The Abbott ARCHITECT stat High Sensitive Troponin-I test can detect much lower levels of troponin, and when combined with gender-specific diagnostic thresholds, can double the rate of heart attack diagnoses in women to levels comparable to the diagnosis rate in men.
Do lower diagnosis rates affect your work in the cath lab?
Are more women admitted for emergency catheterizations due to lower diagnosis rates of heart attack risk? What's your experience?